STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
C
Active, not recruiting
- Fallopian Tube Cancer
- +2 more
- cyclophosphamide
- celecoxib
- Duarte, California
- +1 more
2022-03-17
Mar 17, 2022I
Recruiting
- Solid Tumors
- +2 more
- Cyclophosphamide and JX-594 dose escalation
- +3 more
- Bordeaux, FranceInstitut Bergonie
2022-02-01
Feb 1, 2022K
Recruiting
- Cardio-oncology
- +4 more
- Jinan, Shandong, ChinaQianfoshan Hospital (The First Affiliated Hospital of Shandong F
2021-11-27
Nov 27, 2021H
Recruiting
- Hematological Malignancy
- Detroit, MichiganHenry Ford hospital
2021-12-23
Dec 23, 2021S
Withdrawn
- Chronic Inflammatory Demyelinating Polyneuropathy
- Cyclophosphamide
- (no location specified)
2021-11-02
Nov 2, 2021M
Completed
- Lymphoma
- 2CdA
- +2 more
- Houston, TexasUniversity of Texas MD Anderson Cancer Center
2022-03-03
Mar 3, 2022U
Recruiting
- Metastatic Thyroid Cancer
- Cyclophosphamide
- Sirolimus
- Ann Arbor, MichiganUniversity of Michigan Cancer Center
2021-12-15
Dec 15, 2021S
Not yet recruiting
- Hematopoietic Stem Cell Transplantation
- Drug: Cyclophosphamide
- (no location specified)
2021-06-22
Jun 22, 2021N
Completed
- Lupus Nephritis
- Cairo, EgyptKasr El Aini Hospital
2022-01-04
Jan 4, 2022C
Completed
- Neuroendocrine Tumors
- Metronomic cyclophosphamide
- Interferon-alpha
- Besancon, France
- +1 more
2021-07-30
Jul 30, 2021H
Terminated
- Graft Versus Host Disease
- Cyclophosphamide and Sirolimus
- +3 more
- Hackensack, New JerseyJohn Theurer Cancer Center at Hackensack University Medical Cent
2022-02-04
Feb 4, 2022A
Suspended
- Leukemia, Not Otherwise Specified
- Leukemia, Other
- Cyclophosphamide
- Specimen collection
- Charlotte, North CarolinaLevine Cancer Institute
2022-02-15
Feb 15, 2022N
C
Cyclophosphamide in the Treatment of Associated Acquired Lipodystrophy Syndrome With Type 1 Diabetes
Recruiting
- Lipodystrophy Acquired
- Type1diabetes
- Cyclophosphamide
- Shanghai, Shanghai, ChinaChildren's Hospital of Fudan University
2021-10-21
Oct 21, 2021S
Not yet recruiting
- Breast Cancer
- Nanoxel M
- +3 more
- (no location specified)
2022-01-20
Jan 20, 2022E
Active, not recruiting
- Multiple Myeloma
- Carfilzomib
- +2 more
- Torino, ItalyFondazione EMN Italy Onlus
2022-03-24
Mar 24, 2022E
Active, not recruiting
- Multiple Myeloma
- Carfilzomib
- +2 more
- Torino, ItalyFondazione EMN Italy Onlus
2022-03-24
Mar 24, 2022S
Completed
- HIV
- SB-728-T
- Los Angeles, California
- +10 more
2021-04-26
Apr 26, 2021D
Recruiting
- NSCLC
- +2 more
- Pixatimod
- +2 more
- Pittsburgh, PennsylvaniaUPMC Hillman Cancer Center
2022-03-28
Mar 28, 2022I
Active, not recruiting
- Soft-tissue Sarcomas
- Phase 1: Trabectedin
- +3 more
- Bordeaux, FranceInstitut Bergonié
2021-05-04
May 4, 2021T
Recruiting
- Metastatic Renal Cell Carcinoma
- Cyclophosphamide 50mg
- Pembrolizumab 25 mg/1 ML Intravenous Solution [KEYTRUDA]
- Cambridge, United Kingdom
- +3 more
2022-02-01
Feb 1, 2022N
Active, not recruiting
- Adult T-Cell Leukemia (ATL)
- LMB-2
- +2 more
- Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
2022-01-13
Jan 13, 2022D
Recruiting
- GVHD
- Hematologic Neoplasms
- Cyclophosphamide
- +3 more
- La Jolla, CaliforniaUC San Diego Moores Cancer Center
2022-03-21
Mar 21, 2022U
Recruiting
- Advanced Soft-tissue Sarcoma
- Metastatic Soft-tissue Sarcoma
- Doxorubicin
- Cyclophosphamide
- Toulouse, FranceInstitut Claudius Reagaud-IUCT Oncopôle
2021-09-27
Sep 27, 2021H
Completed
- Chronic Fatigue Syndrome (CFS)
- Myalgic Encephalomyelitis (ME)
- Cyclophosphamide
- Bergen, NorwayDept. of Oncology, Haukeland University Hospital
2021-05-10
May 10, 2021